1 / 12

Generic Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Fore

Global generic drugs market is driven by the prevalence of various diseases, need for cost effective drugs for treatment, and government initiatives to increase the use of generic drugs. In addition, favourable regulatory policies, expiry of the branded drugs, and growth in biosimilars segment are expected to boost the generics drugs market. Furthermore, participants in the supply chain such as wholesalers, retailers and pharmacies also benefit from the sale of the generic drugs with high margins compared to branded generics. This emerged as key driver for the growth of global generic drugs market. However, lack of awareness about the availability of generic drugs, competition from branded generics and lack of price control are hampering the generic drugs market

saikrishna
Télécharger la présentation

Generic Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Fore

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Precision Business Insights (PBI) We provide answers to your questions and deliver actionable insights Agile. Accurate. Actionable Insights sales@precisionbusinessinsights.com Precision Business Insights

  2. Generic Drugs Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 sales@precisionbusinessinsights.com Precision Business Insights 2

  3. Generic Drugs Market Generic Drugs market: A generic drug is pharmaceutical drug, which is bio equivalent to branded drug. Generic drugs are usually approved after patent expiration of patent drugs. Global Market Outline: Generic Drugs Market Global generic drugs market is driven by the prevalence of various diseases, need for cost effective drugs for treatment, and government initiatives to increase the use of generic drugs. In addition, favourable regulatory policies, expiry of the branded drugs, and growth in biosimilars segment are expected to boost the generics drugs market. Furthermore, participants in the supply chain such as wholesalers, retailers and pharmacies also benefit from the sale of the generic drugs with high margins compared to branded generics. This emerged as key driver for the growth of global generic drugs market. However, lack of awareness about the availability of generic drugs, competition from branded generics and lack of price control are hampering the generic drugs market. Generic Drugs market segmented based on therapeutic area and distribution channel Based on therapeutic area, global generic drugs market is segmented into Cardiovascular CNS Antibiotics Oncology Gastrointestinal Hormones Pain Management Others Based on distribution channel, global generic drugs market is segmented into Hospital Pharmacies Retail Pharmacies Online Pharmacies Others sales@precisionbusinessinsights.com Precision Business Insights 3

  4. Generic Drugs Market Generic drugs market is highly fragmented market, presence of large players and small players. To improve their market position in generic drug market companies are adopting strategies like expanding their market presence through collaboration and entering into new markets. For instance, in January 2017, Medical inhaler company Vectura Group PLC collaborated with Sandoz, a division of Novartis AG, to develop a generic version of an inhaler therapy for asthma and COPD (chronic obstructive pulmonary disease). In January 2016, Momenta collaborated with Mylan Laboratories for the development, manufacture and commercialization of six of its biosimilar candidates, including M834, Orencia (abatacept) a biosimilar candidate. Mergers and acquisitions are key strategies adopted by various market players. For instance, in August 2016, Teva Pharmaceutical Industries Ltd Acquired Allergen’s generic business Actavis Generics to expand their product, R&D portfolio and geographical footprint in generic market. A sample of this report is available upon request @ https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/#ulp-4H8Z4LpNMLEuOnnx Geographically generic drugs market segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America generic drugs market is expected to grow at significant rates owing to availability of more number of generics, increase awareness about the generic drugs and favourable regulatory policies and acts such as Affordable Care Act 2010. In Europe region, Belgium and UK expected to grow at notable rates owing to prevalence of chronic diseases, increase in investment on biosimilars, and increase awareness about generic drugs. Asia Pacific Region expected to be fastest growing due to increased government initiatives in usage of generic drugs and increase in awareness about generic drugs. Especially emerging countries like India government initiating different policies and schemes to boost the usage of generic drugs, For instance, Government of India taken an initiative of opening Jan aushadhi stores to make available quality generic medicines at affordable prices to all citizens. To view TOC of this report is available upon request @ https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/#ulp-c654SbFYO64MsOhu sales@precisionbusinessinsights.com Precision Business Insights 4

  5. Generic Drugs Market Some of the market players in generics market are Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), Teva Pharmaceutical Industries, Ltd. (Israel), Dr Reddy’s Laboratories (India), Novartis AG (Sandoz International GmbH) (Switzerland), Apotex Holdings Inc. (Canada), Endo International plc (U.S.), Pfizer Inc. (U.S.), Johnson & Johnson Services Inc., (Janssen Pharmaceutica) (U.S.), LupinLimited (India), Merck & Co, Inc. (U.S.), Mitsubishi Tanabe Pharma (Japan), Momenta Pharmaceuticals (U.S.), Nexus Pharmaceuticals (U.S.), and Novo Nordisk (Denmark) to name a few. In August 2017, Nexus Pharmaceuticals got U.S. FDA approval for the first generic version of Hospira’s Isuprel, for the treatment of bradycardia, heart block. In January 2015, Ivax Pharmaceuticals, a subsidiary of Teva Pharmaceuticals has got FDA approval for first generic version of AstraZeneca’s Nexium to treat gastroesophageal reflux disease (GERD). Need more information about this report @ https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/#ulp-14mlyhjMGhVjZqa3 Report Outline: The report provides granular level information about the market size, regional market share and forecast from 2017-2023 The report covers in-detail insights about the competitor’s overview, key findings and their key strategies The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry The report tracks recent innovations, key developments and startup’s details that are working in the industry The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario Get access to full summary @ https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/ sales@precisionbusinessinsights.com Precision Business Insights 5

  6. About Precision Business Insights sales@precisionbusinessinsights.com Precision Business Insights 6

  7. Why PBI Contact us Industries we serve About Precision Business Insights Our Services Inside About Precision Business Insights Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement new research methodologies to achieve We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and research services based on our client needs. About Precision Business Insights better results. Mission, Vision, Values customised market Industries we serve Our Services Mission Why PBI Precision Business Insights mission is to provide high- quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth. Contact Us Vision Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights sales@precisionbusinessinsights.com Precision Business Insights

  8. Why PBI Contact us Industries we serve About Precision Business Insights Our Services Our Track Record Industries Domains we serve 2K Research Reports Repository Veterinary Medical Devices Biotechnology 30 Active Projects 5 Food and Beverages Pharmaceuticals Agriculture Regions Coverage sales@precisionbusinessinsights.com Precision Business Insights

  9. Why PBI Contact us Industries we serve About Precision Business Insights Our Services Fuel your business by Fuel your business by our services Our Core Areas Syndicated Research Custom Research our services Competitive Intelligence Consulting Services Company Profiles IP Landscapes Our insights provides lucid view about current market trends Product Landscapes Open Innovation Start-ups Assessment sales@precisionbusinessinsights.com Precision Business Insights

  10. WhyPBI Contactus Industries weserve About Precision BusinessInsights OurServices Our Report Visualization Our report provides 5 years of historical values (2012- 2016) and 7 forecast years(2017-2023) 12 years PBI providesupdated report for purchase 6 your earlier months Free customization forevery report 10% Precision Business Insights sales@precisionbusinessinsights.com

  11. WhyPBI Contactus Industrieswe serve About Precision Business Insights OurServices PRE AND POST SALESUPPORT SPECIAL PRICING AND DISCOUNTS  Get in touch with our industry experts to resolve your research  Avail special pricing for the purchase of report sections, queries before and after buying the report regional insights, and historical data  Avail free 60 minutes analyst tele-call to get additional market  Discounts for government bodies, research institutes, information before and after purchase universities, NGO’s and start-up’s ACCURATE AND RELIABLE MARKETDATA NICHE AND GROWTH MARKETSEXPERTISE  Utmost focus on delivering accurate and reliable research  Proven expertise in delivering new and emerging markets product reports and technology advancements  We adopt internally developed data mining tools to eliminate  We provide market information across the developed and emerging any data errors markets ADHERING TO QUICK DELIVERYTIMELINES IN-DEPTH MARKETANALYSIS  We provide impeccable research reports in quick turnaround  Our research reports provides holistic market information with 360 time degree analysis.  We adopt 3 pronged strategy to analyse the market i.e. secondary research, primary research, and expert validation Precision Business Insights sales@precisionbusinessinsights.com

  12. Why PBI Contact us Industries we serve About Precision Business Insights Our Services Europe Office: Asia-Pacific Office: Kemp House, #202, RVS Sree Homes, Opp : Bharat Precision Business Insights (PBI) 152 – 160 City Road, Petroleum Pump, London EC1V 2NX Khanamet Road, Hitech City, Hyderabad, Telangana, India. Pin: 500084 Email: sales@precisionbusinessinsights.com Toll Free (US): +1-866-598-1553 Connect to us: Precision Business Insights

More Related